What is MaxCyte's pre-tax income?

MaxCyte (MXCT) reported pre-tax income of -$4.75M in Q1 2026.

How has MaxCyte's pre-tax income changed year-over-year?

MaxCyte's pre-tax income increased by 53.7% year-over-year, from -$10.26M to -$4.75M.

What is the long-term trend for MaxCyte's pre-tax income?

Over 2 years (2023 to 2025), MaxCyte's pre-tax income has grown at a 8.5% compound annual growth rate (CAGR), from -$37.92M to -$44.63M.

What does pre-tax income mean?

Total income from all sources — operating income plus non-operating items like interest income, investment gains, and other income — before the provision for income taxes.

MaxCyte MXCT Pre-Tax Income

Pre-Tax Income at other companies

Bio-Rad LaboratoriesBIO

-$689.8M-927%

Thermo Fisher ScientificTMO

$1.73B+7.0%

Ginkgo BioworksDNA

-$76.14M+8.5%

Immix Biopharma, Inc.IMMX

-$10.09M-123%

PDE

Pro-Dex, Inc.PDEX

$5.34M+17.3%

RepligenRGEN

$1.77M-77.7%

Other financials

Income statement

See full

Revenue$9.7M-7.1%

Gross profit$8.1M-9.1%

Operating income-$6.2M+49.7%

Net income-$4.8M+53.7%

EPS (diluted)-$0.04+60.0%

Balance sheet

See full

Cash & equivalents$14.6M-37.8%

Total debt$17.5M-7.1%

Total equity$167.9M-15.8%

Total assets$194.5M-15.4%

Cash flow

See full

Operating cash flow-$8.2M+43.3%

CapEx$72.0K-89.0%

Free cash flow-$8.2M+45.3%

Valuation

See full

Market cap$130.15M-46.8%

Enterprise value$133.08M-46.3%

P/S4×-2.8×

Profitability

See full

Gross margin80.5%-0.4pp

Operating margin-141.8%+6.4pp

Net margin-121.2%+12.3pp

FCF margin-90.9%+3.7pp

Returns & leverage

See full

Return on equity-21.3%+2.0pp

Debt / equity0.1×0.0×

Current ratio12×-0.2×

Where this comes from

Reported directly by MaxCyte in its filing.

Tagged under the XBRL concept us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest.

The official record: MaxCyte’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about MaxCyte's pre-tax income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is MaxCyte's pre-tax income?: MaxCyte (MXCT) reported pre-tax income of -$4.75M in Q1 2026.
How has MaxCyte's pre-tax income changed year-over-year?: MaxCyte's pre-tax income increased by 53.7% year-over-year, from -$10.26M to -$4.75M.
What is the long-term trend for MaxCyte's pre-tax income?: Over 2 years (2023 to 2025), MaxCyte's pre-tax income has grown at a 8.5% compound annual growth rate (CAGR), from -$37.92M to -$44.63M.
What does pre-tax income mean?: Total income from all sources — operating income plus non-operating items like interest income, investment gains, and other income — before the provision for income taxes.